Le Lézard
Classified in: Business
Subject: INO

Thinking about buying stock in Pliant Therapeutics, Esperion Therapeutics, Murphy Canyon Acquisition Corp, Limbach Holdings, or Vaccitech?


NEW YORK, Sept. 26, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PLRX, ESPR, CDT, LMB, and VACC.

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

  1. PLRX: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=PLRX&prnumber=092620232
  2. ESPR: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ESPR&prnumber=092620232
  3. CDT: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=CDT&prnumber=092620232
  4. LMB: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=LMB&prnumber=092620232
  5. VACC: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=VACC&prnumber=092620232

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

SOURCE InvestorsObserver


These press releases may also interest you

at 02:27
Asahi India Glass...

at 02:15
Announces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing Novavax's Matrix-MTM adjuvantThis agreement represents a...

at 02:12
Skanska and its joint venture partner, B. Bell Builders, have signed a contract for a new building adjacent to McNair Hall at Rice University in Houston, Texas, USA. Skanska's share of the contract is worth USD 48M, about SEK 500M, which will be...

at 02:05
CRH plc (LSE:CRH):   Key Highlights      Summary Financials Q1 2024 Change     Total revenues $6.5bn +2%     Net income $114m n/m1    ...

at 02:00
Agreement provides individuals with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 onwardsProvides Novavax with cash and an equity investment totalling approximately $1.2 billion...

at 01:42
Skanska has received a supplemental award under a contract with an existing client to build a data center in Arizona, USA. The supplemental award is worth USD 150M, about SEK 1.6 billion, which will be included in the US order bookings for the second...



News published on and distributed by: